Pharming (PHAR) Tax Provisions (2020 - 2026)
Pharming's (PHAR) quarterly Tax Provisions came in at -$1.9 million in Q2 2026, up 66.94% YoY from -$1.1 million in Q2 2025, and down 305.45% on a QoQ basis from -$459000.0 in Q1 2026.
Pharming (PHAR) Tax Provisions (2020 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Tax Provisions data on file, last reported at -$1.9 million in Q2 2026.
- Quarterly Tax Provisions rose 66.94% year-over-year to -$1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$2.3 million (up 80.79% YoY) and the FY2025 annual result came in at $10.3 million, up 207.85% from the prior year.
- Tax Provisions fell to -$1.9 million in Q2 2026, from -$459000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $4.5 million in Q1 2023 to a low of -$5.6 million in Q2 2025.
- A 5-year average of -$676000.4 and a median of -$100002.6 in 2022 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 143714385.71% in 2024, down 128807792.31% in 2024.
- Tracing PHAR's Tax Provisions over 5 years: stood at -$4.8 million in 2022, then surged by 100.0% to $2.6 in 2023, then tumbled by 128807792.31% to -$3.3 million in 2024, then jumped by 100.0% to $0.5 in 2025, then slumped by 372200100.0% to -$1.9 million in 2026.
- The last three Tax Provisions figures came in at -$1.9 million (Q2 2026), -$459000.0 (Q1 2026), and $0.5 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | -1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.86 Mn |
| Mar 31, 2026 | -459,000.00 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | -5.20 |
| Jun 30, 2025 | -5.63 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -3.35 Mn |
| Sep 30, 2024 | -2.50 |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 4.18 Mn |
| Dec 31, 2023 | 2.60 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | -2.10 |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | -4.80 Mn |
| Sep 30, 2022 | -200,000.00 |
| Jun 30, 2022 | -3.79 Mn |
| Mar 31, 2022 | -800,000.00 |
| Dec 31, 2021 | 7.07 Mn |
| Sep 30, 2021 | -1.75 Mn |